Art

J-GLOBAL ID：201702233173770271   Reference number：17A0280368

Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristics

乳癌におけるシグナル伝達経路分子の広範囲な分析:臨床病理特徴との関連

Author (12)： HORII Rie (Japanese Foundation for Cancer Res., Tokyo, JPN) ,  MATSUURA Masaaki (Japanese Foundation for Cancer Res., Tokyo, JPN) ,  DAN Shingo (Japanese Foundation for Cancer Res., Tokyo, JPN) ,  USHIJIMA Masaru (Japanese Foundation for Cancer Res., Tokyo, JPN) ,  UEHIRO Natsue (Japanese Foundation for Cancer Res., Tokyo, JPN) ,  OGIYA Akiko (Japanese Foundation for Cancer Res., Tokyo, JPN) ,  HONMA Naoko (Japanese Foundation for Cancer Res., Tokyo, JPN) ,  HONMA Naoko (Tokyo Metropolitan Inst. of Gerontology, Tokyo, JPN) ,  ITO Yoshinori (Japanese Foundation for Cancer Res., Tokyo, JPN) ,  IWASE Takuji (Japanese Foundation for Cancer Res., Tokyo, JPN) ,  YAMORI Takao (Japanese Foundation for Cancer Res., Tokyo, JPN) ,  AKIYAMA Futoshi (Japanese Foundation for Cancer Res., Tokyo, JPN)
Material： International Journal of Clinical Oncology  (Int J Clin Oncol)
Volume： 20  Issue： 3  Page： 490-498  Publication year： Jun. 2015 
JST Material Number： L3966A  ISSN： 1341-9625  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *breast tumor ,...
Semi thesaurus term： *cellular signal transduction ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0280368&from=J-GLOBAL&jstjournalNo=L3966A") }}

JST classification (2)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N) ,  Clinical oncology in general  (GE03010Y)

Reference (24)：

• Vogelstein B, Papadopoulos N, Velculescu VE et al (2013) Cancer genome landscapes. Science 339:1546-1558
• Kong D, Yamori T (2008) Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy. Cancer Sci 99:1734-1740
• Di Nicolantonio F, Arena S, Tabernero J et al (2010) Deregulation of the PI3 K and KRAS signaling pathways in human cancer cells determines their response to everolimus. J Clin Invest 120:2858-2866
• Bollag G, Hirth P, Tsal J et al (2010) Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 467:596-599
• Serra V, Markman B, Scaltriti M et al (2008) NVP-BEZ235, a dual PI3 K/mTOR inhibitor, prevents PI3 K signaling and inhibits the growth of cancer cells with activating PI3 K mutations. Cancer Res 68:8022-8030

Terms in the title (5)： 乳癌 ,  シグナル伝達経路 ,  分子 ,  分析 ,  臨床病理